Literature DB >> 11576029

Marijuana abstinence effects in marijuana smokers maintained in their home environment.

A J Budney1, J R Hughes, B A Moore, P L Novy.   

Abstract

BACKGROUND: Although withdrawal symptoms are commonly reported by persons seeking treatment for marijuana dependence, the validity and clinical significance of a marijuana withdrawal syndrome has not been established. This controlled outpatient study examined the reliability and specificity of the abstinence effects that occur when daily marijuana users abruptly stop smoking marijuana.
METHODS: Twelve daily marijuana smokers were assessed on 16 consecutive days during which they smoked marijuana as usual (days 1-5), abstained from smoking marijuana (days 6-8), returned to smoking marijuana (days 9-13), and again abstained from smoking marijuana (days 14-16).
RESULTS: An overall measure of withdrawal discomfort increased significantly during the abstinence phases and returned to baseline when marijuana smoking resumed. Craving for marijuana, decreased appetite, sleep difficulty, and weight loss reliably changed across the smoking and abstinence phases. Aggression, anger, irritability, restlessness, and strange dreams increased significantly during one abstinence phase, but not the other. Collateral observers confirmed participant reports of these symptoms.
CONCLUSIONS: This study validated several specific effects of marijuana abstinence in heavy marijuana users, and showed they were reliable and clinically significant. These withdrawal effects appear similar in type and magnitude to those observed in studies of nicotine withdrawal.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11576029     DOI: 10.1001/archpsyc.58.10.917

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  80 in total

Review 1.  Endocannabinoid signalling in reward and addiction.

Authors:  Loren H Parsons; Yasmin L Hurd
Journal:  Nat Rev Neurosci       Date:  2015-09-16       Impact factor: 34.870

2.  Magnitude and duration of cue-induced craving for marijuana in volunteers with cannabis use disorder.

Authors:  Leslie H Lundahl; Mark K Greenwald
Journal:  Drug Alcohol Depend       Date:  2016-07-18       Impact factor: 4.492

Review 3.  Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer's Disease.

Authors:  Celina S Liu; Sarah A Chau; Myuri Ruthirakuhan; Krista L Lanctôt; Nathan Herrmann
Journal:  CNS Drugs       Date:  2015-08       Impact factor: 5.749

Review 4.  The marijuana withdrawal syndrome: diagnosis and treatment.

Authors:  Margaret Haney
Journal:  Curr Psychiatry Rep       Date:  2005-10       Impact factor: 5.285

5.  Incremental validity of anxiety sensitivity in relation to marijuana withdrawal symptoms.

Authors:  Marcel O Bonn-Miller; Michael J Zvolensky; Erin C Marshall; Amit Bernstein
Journal:  Addict Behav       Date:  2006-12-19       Impact factor: 3.913

6.  Receptor subtypes and signal transduction mechanisms contributing to the estrogenic attenuation of cannabinoid-induced changes in energy homeostasis.

Authors:  Neal Washburn; Amanda Borgquist; Kate Wang; Garrett S Jeffery; Martin J Kelly; Edward J Wagner
Journal:  Neuroendocrinology       Date:  2012-08-28       Impact factor: 4.914

7.  A within-subject comparison of withdrawal symptoms during abstinence from cannabis, tobacco, and both substances.

Authors:  R G Vandrey; A J Budney; J R Hughes; A Liguori
Journal:  Drug Alcohol Depend       Date:  2007-07-23       Impact factor: 4.492

Review 8.  Marijuana dependence: not just smoke and mirrors.

Authors:  Divya Ramesh; Joel E Schlosburg; Jason M Wiebelhaus; Aron H Lichtman
Journal:  ILAR J       Date:  2011

9.  Behavioral treatment for marijuana dependence: randomized trial of contingency management and self-efficacy enhancement.

Authors:  Mark D Litt; Ronald M Kadden; Nancy M Petry
Journal:  Addict Behav       Date:  2012-08-31       Impact factor: 3.913

10.  Long-lasting increase of alcohol relapse by the cannabinoid receptor agonist WIN 55,212-2 during alcohol deprivation.

Authors:  José Antonio López-Moreno; Gustavo González-Cuevas; Fernando Rodríguez de Fonseca; Miguel Navarro
Journal:  J Neurosci       Date:  2004-09-22       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.